Which has been the strongest short-term theme?

financials healthcare biotech specialist ETF

8 October 2021
| By Laura Dew |
image
image
expand image

Investors are accused of being ‘theme junkies’ as they chase the latest mega-trend but which theme has seen the strongest returns?

Earlier this month, chief investment officer at Montaka Global Investments, Andrew Macken, said investors were chasing trends which were being ‘spruiked’ by asset managers looking to capture the demand for thematic investments.

“It almost feels like investors are looking for a new decade-long theme… every two weeks. Investors have become theme junkies,” he said.

While investors should play out a theme over the long-term, which one had performed best over the past year?

According to FE Analytics, over one year to 31 August, 2021, there was a clear win for those funds which were focused on financials.

The top performer was VanEck Australian Banks ETF which returned 52.9% followed by BetaShares Australian Financials ETF which returned 44.9%.

This was followed by SSgA SPDR S&P/ASX 200 Financials ex A-REITs and BetaShares Global Banks ETF Currency Hedged which returned 44.7% and 44% respectively.

These four funds compared to returns of 30.3% by the specialist sector over the same period within the Australian Core Strategies universe.

Performance of financial funds versus sector over one year to 31 August 2021

At the other end of spectrum, the lowest one-year returns had come from healthcare and biotech vehicles.

CFS Wholesale Global Health & Biotechnology fund returned 19.6%, ETFS S&P Biotech ETF returned 20.1%, BetaShares Global Healthcare ETF Currency Hedged returned 22.6% and Zurich Investments ACI Healthcare Impact returned 25.8%.

Performance of healthcare funds versus sector over one year to 31 August 2021

Read more about:

AUTHOR

Recommended for you

sub-bgsidebar subscription

Never miss the latest news and developments in wealth management industry

MARKET INSIGHTS

Completely agree Peter. The definition of 'significant change is circumstances relevant to the scope of the advice' is s...

4 weeks 1 day ago

This verdict highlights something deeply wrong and rotten at the heart of the FSCP. We are witnessing a heavy-handed, op...

1 month ago

Interesting. Would be good to know the details of the StrategyOne deal....

1 month 1 week ago

Insignia Financial has confirmed it is considering a preliminary non-binding proposal received from a US private equity giant to acquire the firm. ...

1 week 6 days ago

Six of the seven listed financial advice licensees have reported positive share price growth in 2024, with AMP and Insignia successfully reversing earlier losses. ...

1 week 2 days ago

Specialist wealth platform provider Mason Stevens has become the latest target of an acquisition as it enters a binding agreement with a leading Sydney-based private equi...

1 week 1 day ago